Tower Research Capital LLC (Trc) Novavax Inc Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Novavax Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 10,596 shares of NVAX stock, worth $73,854. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,596
Previous 37,335
71.62%
Holding current value
$73,854
Previous $235,000
61.28%
% of portfolio
0.0%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding NVAX
# of Institutions
307Shares Held
98.4MCall Options Held
5.7MPut Options Held
9.06M-
Vanguard Group Inc Valley Forge, PA15.2MShares$106 Million0.0% of portfolio
-
Shah Capital Management14.6MShares$101 Million48.17% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$82.6 Million0.0% of portfolio
-
State Street Corp Boston, MA7.2MShares$50.2 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.27MShares$29.8 Million0.02% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $545M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...